ライフサイエンスコーパス: exercise test

1 est short-term risk (ie, older age, abnormal exercise test).

2 tan procedure and subsequent cardiopulmonary exercise test.

3 ases who had negative results in the wheat + exercise test.

4 on, and CRF assessed using a treadmill-based exercise test.

5 CRF was quantified by a maximal treadmill exercise test.

6 Fitness was measured by a maximal treadmill exercise test.

7 ty risk in individuals undergoing a clinical exercise test.

8 antly improves the diagnostic performance of exercise test.

9 ise capacity, was used as the outcome of the exercise test.

10 during at least 1 mental test or during the exercise test.

11 ith methacholine challenge being superior to exercise test.

12 ients with asymptomatic severe AS and normal exercise test.

13 stable conditions) underwent cardiopulmonary exercise test.

14 children completed a symptom-limited maximal exercise test.

15 n female elite athletes underwent a day-long exercise test.

16 on and performed a maximal incremental cycle exercise test.

17 with SCA underwent CMR, echocardiography and exercise test.

18 symptom-limited Naughton protocol treadmill exercise tests.

19 state and before and after two standardized exercise tests.

20 rpreting patterns of change during the short exercise tests.

21 l blood gases were collected throughout both exercise tests.

22 n=10) underwent MR-augmented cardiopulmonary exercise testing.

23 nance imaging (CMRI), Holter monitoring, and exercise testing.

24 hic cardiomyopathy underwent cardiopulmonary exercise testing.

25 965 patients undergoing clinically indicated exercise testing.

26 urvivors of acute MI and patients undergoing exercise testing.

27 quantified as duration of maximal treadmill exercise testing.

28 of their maximum-predicted heart rate during exercise testing.

29 stress echocardiography and cardiopulmonary exercise testing.

30 imum upright cycle ergometry cardiopulmonary exercise testing.

31 nance for ventricular function and metabolic exercise testing.

32 ar magnetic resonance, echocardiography, and exercise testing.

33 ecific quality of life instruments and short exercise testing.

34 ere studied with incremental cardiopulmonary exercise testing.

35 ting, pharmacologic interventions, and acute exercise testing.

36 emodynamics underwent supine lower extremity exercise testing.

37 pliance and arterial elastance), and maximal exercise testing.

38 ts, 6-min walking tests, and cardiopulmonary exercise testing.

39 unction who are referred for cardiopulmonary exercise testing.

40 st Physicians (ATS/ACCP) recommendations for exercise testing.

41 , echocardiography, and invasive hemodynamic exercise testing.

42 ainide or placebo) for 3 months, followed by exercise testing.

43 dietary intake determined in the 4 d before exercise testing.

44 the incidence of HF in veterans referred for exercise testing.

45 ebo or flecainide) for 3 months, followed by exercise testing.

46 derwent clinically indicated cardiopulmonary exercise testing.

47 hort comprising patients undergoing clinical exercise testing.

48 0.005) but no relations with cardiopulmonary exercise testing.

49 of 31 included patients performed a maximal exercise test (15 boys, 11.6 +/- 2.9 years, weight, 40.9

50 After 27 +/- 15 months from the most recent exercise test, 19 patients died or were re-heart transpl

51 clinical examination, ECG, echocardiography, exercise testing, 24h Holter ECG, and cardiac magnetic r

52 ak oxygen consumption in the cardiopulmonary exercise test, 6-min walk test, and quality of life.

53 underwent echocardiography, cardiopulmonary exercise testing, 6-minute walking test, isokinetic musc

54 in 134 patients referred for cardiopulmonary exercise testing: 79 with HFpEF and 55 controls.

55 During a hypoxia exercise test, a dose-dependent hypoxia-induced decrease

56 and after cooling were <20%, a repeat short exercise test after rewarming was useful in patients wit

57 ation was significantly higher than that for exercise test alone (0.84 versus 0.78; P=0.007).

58 failure (HF), during maximal cardiopulmonary exercise test, anaerobic threshold (AT) is not always id

59 Cardiopulmonary exercise test and 6-minute walking test are frequently u

60 All patients underwent a cardiopulmonary exercise test and a phosphorus magnetic resonance spectr

61 ged 12 to 60 years underwent cardiopulmonary exercise test and echocardiography 1 day before transcat

62 Between 2001 and 2009, using cardiopulmonary exercise test and echocardiography, we studied 82 childr

63 metabolic equivalents (MET) achieved during exercise test and eight categories based on fitness stat

64 receiver operating characteristic curve for exercise test and global longitudinal peak systolic stra

65 ic equivalents [METs]) and were compared for exercise test and imaging outcomes, particularly the pre

66 gated the association between HR response to exercise testing and age with prognosis in 5437 asymptom

67 functional outcomes included cardiopulmonary exercise testing and arterial compliance.

68 All subjects underwent cardiopulmonary exercise testing and cardiac magnetic resonance imaging,

69 ontrol subjects (n = 146) underwent invasive exercise testing and echocardiographic assessment of car

70 Patients underwent cardiopulmonary exercise testing and echocardiography to assess systolic

71 ventional methods, including cardiopulmonary exercise testing and echocardiography.

72 Exercise testing and EF were assessed 4 and 12 weeks aft

73 with HFpEF and 13 senior controls underwent exercise testing and graded isoproterenol infusion to qu

74 Participants underwent exercise testing and measurement of left ventricular EF

75 CHF as assessed by symptom-limited treadmill exercise testing and measurement of peak oxygen consumpt

76 Cardiopulmonary exercise testing and metabolite profiling was performed

77 Epinephrine infusion combined with exercise testing and targeted genetic testing is recomme

78 nce in selected patients with early-positive exercise testing and those with frequent angina.

79 ow more reliable interpretation of the short exercise tests and aid accurate DNA-based diagnosis.

80 multivariable adjustment for baseline data, exercise test, and conventional echocardiography (odds r

81 rols using needle electromyography, the long exercise test, and short exercise tests at room temperat

82 ine healthy participants performed a maximal-exercise test, and two 30 min sessions of semi-recumbent

83 ne Doppler echocardiography, cardiopulmonary exercise testing, and cardiac MRI.

84 diography, echocardiography, cardiopulmonary exercise testing, and cardiovascular magnetic resonance

85 resonance, a comprehensive biomarker panel, exercise testing, and clinical events over 6 months.

86 al data, ECG, laboratory and cardiopulmonary exercise testing, and echocardiography.

87 diography, echocardiography, cardiopulmonary exercise testing, and genetic testing in predicting the

88 Echocardiography, cardiopulmonary exercise testing, and laboratory evaluation were perform

89 sectional study, extensive echocardiography, exercise testing, and NT-proBNP measurements were perfor

90 acute hypoxic (15% inspired oxygen) maximal exercise tests, and then compared their results to match

91 ardiovascular magnetic resonance imaging and exercise testing are important in the risk assessment of

92 Biomarkers and cardiopulmonary exercise testing are well validated in the prediction of

93 In the long exercise test, area decrements from pre-exercise baselin

94 ifferences in the normative data of the long exercise test argue for the use of appropriate ethnicall

95 The use of exercise testing as an objective assessment of cardiores

96 %) underwent symptom-limited cardiopulmonary exercise testing as part of routine management and were

97 ean+/-SD, 71.4+/-5.0 years) who completed an exercise test at the Veterans Affairs Medical Centers in

98 243 HTx recipients performed cardiopulmonary exercise testing at 1 year after HTx.

99 ssed by the Seattle Angina Questionnaire and exercise testing at 6 and 12 months.

100 ge, 33+/-13 years) underwent cardiopulmonary exercise testing at a single center over a period of 10

101 n consumption, measured with cardiopulmonary exercise testing at baseline and 8 and 24 weeks.

102 y aged 18-30 in 1985 who underwent treadmill exercise testing at baseline visit, and 2,735 participan

103 myography, the long exercise test, and short exercise tests at room temperature, after cooling, and r

104 We performed echocardiography and maximal exercise tests at sea level (344 m), and following 5-10

105 otal of 1,326 persons went through a hypoxic exercise test before a sojourn above 4,000 m.

106 nge 26-86 years) underwent cardiorespiratory exercise testing before major hepatobiliary surgery at a

107 All completed an exercise test between 1986 and 2011 with no evidence of

108 formed a submaximal invasive cardiopulmonary exercise test between January 2013 and July 2014.

109 rcise capacity (peak VO2) on cardiopulmonary exercise testing, both measured at 12 months.

110 r that can be defined during cardiopulmonary exercise testing, but rise rapidly at higher intensities

111 Conventional cardiopulmonary exercise testing can objectively measure exercise intole

112 workup, including ECG, signal averaged ECG, exercise testing, cardiac imaging, Holter-monitoring, an

113 or impaired performance on a low-technology exercise test, cardiopulmonary exercise testing should b

114 Compared with traditional exercise tests, cardiopulmonary exercise testing (CPET)

115 Using cardiopulmonary exercise testing, cardiovascular reserve was evaluated i

116 and were regularly tested (echocardiograms, exercise tests, catheterizations) with the pump at low s

117 Cardiac MRI, echocardiography, metabolic exercise testing, chest radiography, and hemodynamics be

118 Cardiopulmonary exercise test combined with simultaneous exercise echoca

119 The aim of this study was to determine if exercise testing could expose a latent electrical substr

120 Laboratory-based cardiopulmonary exercise testing coupled with serial phlebotomy was used

121 A cardiopulmonary exercise test (CPET) with expired gas analysis was used

122 The prognostic value of cardiopulmonary exercise testing (CPET) for survival in cystic fibrosis

123 ult patients, the utility of cardiopulmonary exercise testing (CPET) in children as a prognostic tool

124 alyses concerning the use of cardiopulmonary exercise testing (CPET) in preoperative risk evaluation

125 traditional exercise tests, cardiopulmonary exercise testing (CPET) provides a thorough assessment o

126 Cardiopulmonary exercise testing (CPET) was used to objectively assess c

127 Cardiopulmonary exercise test (CPX) responses are strong predictors of o

128 In the past several decades, cardiopulmonary exercise testing (CPX) has seen an exponential increase

129 Cardiopulmonary exercise testing (CPX) with measurement of peak oxygen u

130 l, electrocardiographic, and cardiopulmonary exercise test data from 332 male professional soccer pla

131 health-related quality of life, imaging, and exercise testing data, we estimated incremental prognost

132 Exercise testing demonstrated significant improvement in

133 t ventricle, during invasive cardiopulmonary exercise testing, demonstrates that that the right heart

134 well either on a 6-minute walk or submaximal exercise testing despite increased right-to-left shuntin

135 in a subset of 572610 men with data from an exercise test did not reduce the associations.

136 Exercise testing, drug provocation, advanced cardiac ima

137 We analyzed all children who underwent exercise testing during HT evaluation at our center betw

138 ger studies are needed to assess the role of exercise testing during HT evaluation in children with a

139 Exercise testing during HT evaluation in children with b

140 kg), who completed invasive cardiopulmonary exercise testing during upright ergometry, while using c

141 ticipants underwent baseline cardiopulmonary exercise testing, echocardiogram, biomarker assessment,

142 height, and weight underwent cardiopulmonary exercise testing, echocardiography including tissue-Dopp

143 (n = 29) underwent invasive cardiopulmonary exercise testing, echocardiography, and assessment of mi

144 ng serum biomarker analysis, cardiopulmonary exercise testing, echocardiography, and cardiac magnetic

145 Subjects were studied with cardiopulmonary exercise testing, echocardiography, and cardiac MRI.

146 Exercise testing, echocardiography, B-type natriuretic p

147 Variables from standardized exercise testing, echocardiography, cardiac magnetic res

148 Exercise testing exposes a latent electrical substrate i

149 n, mean age 59 years) underwent a submaximal exercise test (first 2 stages of the Bruce protocol), ap

150 did a systematic review of studies of formal exercise testing for adults with cancer.

151 cted) who underwent invasive cardiopulmonary exercise testing for unexplained exertional intolerance.

152 d during maximal incremental cardiopulmonary exercise testing from 87 consecutive heart transplant as

153 Cardiopulmonary exercise test, functional class, blood samples, and qual

154 cording to peak VO(2) during cardiopulmonary exercise testing (>14, 10-14, and <10 mL/min per kg).

155 pleting the V4 recording, a treadmill graded exercise test (GXT) was performed, followed by a 5-min a

156 ion computed tomography (MPGS) compared with exercise test has not yet been properly evaluated.

157 An abnormal ECG during maximal exercise testing has been shown to be a powerful predict

158 lar survey, including a standardized bicycle exercise test in 1972 to 1975.

159 at rest and immediately post-cardiopulmonary exercise test in 207 patients (63 +/- 8 years of age) wi

160 rtery occlusion during the last minute of an exercise test in 76 dogs (from 2 independent studies) wi

161 Appropriate, except for calcium scoring and exercise testing in intermediate and high-risk individua

162 on of dyspnea during bronchial challenge and exercise testing in obese patients with asthma and misdi

163 The results of cardiopulmonary exercise testing in patients with structural evidence of

164 These subjects performed maximal exercise tests in normoxia and hypoxia to determine how

165 pleted two symptom-limited incremental cycle exercise tests, in randomized order: unloaded control an

166 2 years; 52.2% male) underwent a mean of 2.7 exercise tests, in which 79 (3.7%) developed NSVT with e

167 Cardiopulmonary exercise testing indices peak oxygen consumption, VE/Vco

168 The added discriminative ability of exercise test information and MPGS was assessed by net r

169 tory, echocardiographic, and cardiopulmonary exercise test investigations at study enrollment.

170 We have demonstrated that a cardiopulmonary exercise test is feasible in ambulatory children with di

171 ion imperative, but although cardiopulmonary exercise test is well established as a powerful tool in

172 gen consumption (peak VO2) <50% predicted on exercise testing is a class I indication for heart trans

173 (CRF) as assessed by formalized incremental exercise testing is an independent predictor of numerous

174 Invasive hemodynamic exercise testing is commonly used in the evaluation of p

175 MR-augmented cardiopulmonary exercise testing is feasible in both healthy children an

176 Cardiopulmonary exercise testing is feasible in children with DCM and is

177 Exercise testing is more sensitive than saline loading t

178 Cardiopulmonary exercise testing is often used to evaluate exercise capa

179 Exercise testing is performed in patients with hypertrop

180 Exercise testing is useful in unmasking QT prolongation

181 in a subset of patients with cardiopulmonary exercise testing, ischemia burden was associated with wo

182 ts; electrophysiological short and prolonged exercise tests; manual muscle testing; and a modified ge

183 These findings suggest that cardiopulmonary exercise testing may be a useful tool to provide an indi

184 Routine cardiopulmonary exercise testing may be a useful tool to provide an indi

185 There is new evidence that exercise testing may provide better diagnostic and progn

186 k distance >/= 380 to 440 m, cardiopulmonary exercise test-measured peak oxygen consumption >15 ml/mi

187 Cardiopulmonary exercise testing measures oxygen uptake at increasing le

188 tween 2004 and 2010 we performed 360 maximal exercise tests (median, 2 tests/patient; range, 1-7) in

189 Overall, the reporting of exercise-testing methods and data for adults with cancer

190 Pre- and post-training cardiopulmonary exercise tests, MRI, and echocardiography, including tis

191 Exercise testing, multimodality imaging, and lower mean

192 hocardiographic (n = 73) and cardiopulmonary exercise test (n = 37) within 30 days were included.

193 e head-up tilt testing (n=11), low-intensity exercise testing (n=11), and beta blockade (n=10).

194 G, Holter, echocardiography, cardiopulmonary exercise testing, N-terminal pro-brain natriuretic pepti

195 established in 1986-1987, underwent a graded exercise test of aerobic fitness to measure maximal oxyg

196 cruited and each underwent 4 cardiopulmonary exercise tests: one incremental and three CWR tests (low

197 as opposed to other prediction tools such as exercise testing or frailty assessment.

198 shown efficacy for ranolazine in increasing exercise testing or reducing anginal episodes or use of

199 < 85% predicted from maximal cardiopulmonary exercise testing; organ functions were ascertained with

200 ale, 8 female) completed three constant load exercise tests over 4 days.

201 The relationship between cardiopulmonary exercise testing parameters and pregnancy outcome has no

202 Cardiopulmonary exercise testing parameters are powerful prognosticators

203 latory power and traditional cardiopulmonary exercise testing parameters can be used to predict progn

204 survival prospects based on cardiopulmonary exercise testing parameters in this growing population.

205 hesized that combinations of cardiopulmonary exercise testing parameters may provide optimal prognost

206 mic status, quality of life, cardiopulmonary exercise testing parameters, and biomarker levels.

207 stroke (360 cases) in the cohort of clinical exercise test patients.

208 (8 men, 12 women) underwent cardiopulmonary exercise testing (peak Vo(2)) and static handgrip exerci

209 sess for association between cardiopulmonary exercise test performance at 1 year after HTx and future

210 , peak oxygen consumption by cardiopulmonary exercise testing (pkVO2), New York Heart Association (NY

211 Exercise testing pre- and post- training included: (a) s

212 nd heart rate reserve during cardiopulmonary exercise testing predicted risk of early mortality when

213 Preoperative cardiopulmonary exercise testing predicts surgical outcome and should th

214 VO(2) max was measured using a standardized exercise testing protocol in patients with stage 2 to 4

215 was to determine whether resting LV-GLS and exercise testing provide incremental prognostic utility

216 Cardiopulmonary exercise testing provides prognostic information in pati

217 Cardiopulmonary exercise testing provides strong prognostic information

218 Exercise testing provoked an abnormal QT response in 42%

219 ure Questionnaire) and cardiac limitation on exercise testing (reduced peak oxygen consumption, 24+/-

220 cations, functional class, laboratory tests, exercise testing results, and hemodynamics.

221 Exercise tests revealed an increase in exercise capacity

222 The median baseline exercise test score was 3.0 (range, 0-4), with no differ

223 peak walking time obtained from a treadmill exercise test; secondary outcome measures included daily

224 radoxical myotonia, and an increase in short exercise test sensitivity post-cooling suggest sodium ch

225 ow-technology exercise test, cardiopulmonary exercise testing should be considered.

226 The short exercise test showed >/=10% decrement in the compound mu

227 p=0.005,)) and fewer minutes completed of an exercise test (sibling odds ratio [OR] 1.59, 95% CI 1.0

228 In patients with negative exercise tests, specific clinical features are helpful i

229 hough specific morphological valve features, exercise testing, stress imaging, and biomarkers can hel

230 ndomisation assessments with cardiopulmonary exercise testing, symptom questionnaires, and dobutamine

231 In patients with negative short exercise tests, symptomatic eye closure myotonia predict

232 for </=7 days on 2 occasions after a maximal exercise test that was used to calibrate the monitor ind

233 ls need to be identified: these will include exercise testing, the composite end point of time to cli

234 In patients undergoing exercise testing, the predictive value of PRD was strong

235 Cardiopulmonary exercise test time increased by 0.48 minute (from 6.79 t

236 s, heart rate recovery after cardiopulmonary exercise testing, time/frequency measures of parasympath

237 ddition, the 30 athletes performed a maximal exercise test to assess aerobic capacity and anaerobic t

238 nts also undergo an invasive cardiopulmonary exercise test to assess changes in hemodynamics and gas

239 tory fitness was assessed using a submaximal exercise test to estimate maximum oxygen consumption adj

240 factor assessment, and incremental treadmill exercise test to evaluate CRF.

241 The participants performed an incremental exercise test to volitional exhaustion to determine VO2

242 tients and controls performed an incremental exercise test to volitional exhaustion to determine VO2

243 tic resonance (MR)-augmented cardiopulmonary exercise testing to achieve this goal and assessed child

244 ients underwent preoperative cardiopulmonary exercise testing to determine their anaerobic threshold

245 er transplantation underwent cardiopulmonary exercise testing to determine ventilatory threshold (VT)

246 n </=40%) patients underwent cardiopulmonary exercise testing to evaluate aerobic performance.

247 respiratory fitness (CRF) algorithms without exercise testing to predict the risk for nonfatal cardio

248 n, laboratory testing, echocardiography, and exercise testing) to baseline clinical assessment for pr

249 onal intolerance undergoing upright invasive exercise testing, tricuspid regurgitation (TR) Doppler e

250 esting data alone and reinforce the value of exercise testing using invasive and noninvasive hemodyna

251 predictor of risk for HF among clinical and exercise test variables (hazard ratio, 1.91; 95% confide

252 iation between HF incidence and clinical and exercise test variables.

253 Cardiopulmonary exercise testing variables included peak oxygen consumpt

254 On cardiopulmonary exercise testing, ventilatory response to carbon dioxide

255 timate physical fitness, a submaximal graded exercise test was performed on a bicycle ergometer.

256 The exercise test was positive accompanied with nasal discha

257 ise duration on the baseline cardiopulmonary exercise test was the most important predictor of both t

258 ate recovery after a maximal cardiopulmonary exercise test was used as a surrogate for parasympatheti

259 ed to study whether low HR at rest or during exercise testing was a predictor of AF in initially heal

260 Preoperative cardiopulmonary exercise testing was included.

261 Exercise testing was performed in 115 children able to e

262 Invasive hemodynamic exercise testing was performed in 46 patients with a rec

263 Cardiovascular responses during maximal exercise testing were assessed in the upright position b

264 l associations between clinical outcomes and exercise testing were examined using interaction testing

265 ts of pulmonary-function and cardiopulmonary-exercise testing were generally within normal population

266 int, Seattle Angina Questionnaire score, and exercise testing were not statistically different in bot

267 denosine bronchial challenge and incremental exercise testing were obtained.

268 MRI and cardiopulmonary exercise testing were performed before and 1 year after

269 Cardiac magnetic resonance imaging and exercise testing were performed prospectively to quantif

270 Parameters of cardiopulmonary exercise testing were recently identified as strong pred

271 proven cardiac limitation by cardiopulmonary exercise testing were studied by standard, tissue Dopple

272 Subsequent constant load exercise tests were iso-time and iso-work rate, but with

273 with systolic heart failure, cardiopulmonary exercise tests were performed at baseline and approximat

274 Maximum incremental cardiopulmonary exercise tests were performed.

275 Exercise tests were scored on an ordinal scale of worst

276 ial predictors, derived from cardiopulmonary exercise testing, were compared with other commonly used

277 nted composite endpoint, anginal status, and exercise testing, were not statistically different betwe

278 pe is an index determined by cardiopulmonary exercise testing, which incorporates pertinent cardiac,

279 dioverter-defibrillator underwent a baseline exercise test while receiving maximally tolerated beta-b

280 ting and a symptom-limited incremental cycle exercise test with arterial blood gas collection.

281 treatment optimization, a progressive cycle exercise test with capillary (c) blood gas collection.

282 s performed a maximal graded cardiopulmonary exercise test with continuous measurements of respirator

283 f 456 subjects performed a 20-minute hypoxia exercise test with continuous recording of ECG and physi

284 ) underwent a symptom-limited supine bicycle exercise test with Doppler echocardiography and respirat

285 Cardiopulmonary exercise testing with echocardiographic assessment of my

286 ol subjects (n=30) underwent cardiopulmonary exercise testing with invasive hemodynamic monitoring an

287 erformed maximum incremental cardiopulmonary exercise testing with invasive hemodynamic monitoring on

288 ction fraction who underwent cardiopulmonary exercise testing with invasive hemodynamic monitoring.

289 % referred for comprehensive cardiopulmonary exercise testing with invasive hemodynamic monitoring.

290 We performed cardiopulmonary exercise testing with invasive monitoring to measure hem

291 ding tissue tagging and 31P spectroscopy and exercise testing with noninvasive central hemodynamic me

292 underwent high-fidelity invasive hemodynamic exercise testing with simultaneous expired gas analysis

293 and 98 HFpEF subjects underwent hemodynamic exercise testing with simultaneous expired gas analysis

294 cm(2), peak jet velocity >3.5 m/s) underwent exercise testing with simultaneous invasive hemodynamic

295 nts with large PFO underwent cardiopulmonary exercise tests with contrast transcranial Doppler, esoph

296 ncentration ([La(-) ]), during a progressive exercise test, with an excess pulmonary carbon dioxide o

297 these abnormalities are more apparent during exercise testing, with little relationship at rest.

298 supine-cycle maximal-effort cardiopulmonary exercise tests, with measurements of cardiac output and

299 rt disease who had undergone cardiopulmonary exercise testing within 2 years of pregnancy or during t

300 Survival after cardiopulmonary exercise testing without HTx or ventricular assist devic